# Metabolic Effects of Angiotensin-(1-7)

> **NCT02646475** · PHASE1 · RECRUITING · sponsor: **Vanderbilt University** · enrollment: 26 (estimated)

## Conditions studied

- Obesity
- Insulin Resistance
- Hypertension
- Metabolic Cardiovascular Syndrome

## Interventions

- **DRUG:** Angiotensin-(1-7)
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02646475
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-02
- **Primary completion:** 2029-12
- **Final completion:** 2029-12
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02646475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02646475, "Metabolic Effects of Angiotensin-(1-7)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02646475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*